Company Encyclopedia
View More
name
Amesite
AMST.US
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
76.60 B
AMST.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Education ServicesIndustry
Industry Ranking39/61
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-146.94%E
    • Profit Margin-1731.90%E
    • Gross Margin100.00%A
  • Growth ScoreB
    • Revenue YoY68.56%A
    • Net Profit YoY24.19%B
    • Total Assets YoY-19.78%E
    • Net Assets YoY-9.39%D
  • Cash ScoreB
    • Cash Flow Margin-5.77%D
    • OCF YoY68.56%A
  • Operating ScoreE
    • Turnover0.07E
  • Debt ScoreA
    • Gearing Ratio16.47%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months

    Shareholder Update Reports Positive Customer Reviews, New Segment Growth and Technology Rollouts across Post-Acute Healthcare Shareholder Update Reports Positive Customer Reviews, New Segment Growth and Technology Rollouts across Post-Acute Healthcare ...

    GlobeNewswire·
    US
    AMST
    +2.49%
    GlobeNewswire·
    US
    AMST
    +2.49%

    Amesite Receives Nasdaq Deficiency Letter for Non-Compliance

    Amesite Inc. (AMST) received a deficiency letter from Nasdaq on October 28, 2025, for non-compliance with Listing Rule 5550(b)(1) due to insufficient stockholders’ equity. The company plans to submit a compliance plan within 45 days, which could extend the compliance period by 180 days if accepted. Shares will continue trading under 'AMST' during this process. Amesite focuses on AI-driven online learning platforms for educational institutions and businesses, with a current market cap of $16.46M.

    Tip Ranks·
    US
    AMST
    +2.49%
    Tip Ranks·
    US
    AMST
    +2.49%

    Amesite Inc. Faces Nasdaq Delisting Risk Over Equity Shortfall

    Amesite Inc. has received a deficiency letter from Nasdaq regarding non-compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing. The company has 45 days to submit a compliance plan. Trading will continue, but there is no guarantee of regaining compliance or receiving an extension. If the plan is rejected, Amesite may request a hearing to delay potential delisting.

    Reuters·
    US
    AMST
    +2.49%
    Reuters·
    US
    AMST
    +2.49%

    Amesite Inc. Files Amendment to Annual Report

    Amesite Inc. has filed an amendment to its annual report on Form 10-K/A, restating Part III, Items 10-14 for the year ended June 30, 2025. The amendment includes previously omitted information and updates the cover page, along with certifications required under Section 302 of the Sarbanes-Oxley Act. No other changes were made to the original report. The full filing is accessible via the provided link.

    Reuters·
    US
    AMST
    +2.49%
    Reuters·
    US
    AMST
    +2.49%

    Amesite Inc. SEC 10-Q Report

    Amesite Inc. has released its Q3 2025 Form 10-Q report, showing improved financial performance with net revenue rising to $0.094 million from $0.011 million. The company reported a reduced loss from operations of $(0.662) million and a net loss of $(0.642) million. A strategic pivot towards the healthcare sector is evident, with 26% of revenue now from individual customers. The launch of the NurseMagic™ app marks this shift. Cost management strategies have been implemented, and future cash generation plans include potential stock offerings, subject to market conditions.

    TradingView·
    US
    AMST
    +2.49%
    TradingView·
    US
    AMST
    +2.49%
    © 2025 Longbridge｜Disclaimer